SkinHealth Systems Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $300.8M | $334.3M | $398.0M | $365.9M | $260.1M | $119.1M | $166.6M |
| Cost of Revenue | $104.4M | $152.0M | $242.9M | $117.1M | $81.5M | $51.9M | $60.1M |
| Gross Profit | $196.4M | $182.3M | $155.1M | $248.8M | $178.5M | $67.2M | $106.5M |
| Gross Margin | 65.3% | 54.5% | 39.0% | 68.0% | 68.6% | 56.4% | 63.9% |
| Operating Expenses | |||||||
| Research & Development | $5.6M | $6.3M | $10.1M | $8.4M | $8.2M | $3.4M | $4.6M |
| SG&A Expense | $117.9M | $125.5M | $131.4M | $106.1M | $98.7M | $30.6M | $26.7M |
| Operating Income | $-20.8M | $-67.8M | $-130.9M | $-25.8M | $-39.9M | $-17.2M | $13.5M |
| Operating Margin | -6.9% | -20.3% | -32.9% | -7.1% | -15.4% | -14.4% | 8.1% |
| Interest Expense | — | — | $13.6M | $13.4M | $11.8M | — | — |
| Pretax Income | $-5.9M | $-29.6M | $-101.9M | $45.3M | $-380.6M | $-38.5M | $-2.9M |
| Income Tax Expense | $3.6M | $-452.0K | $-1.8M | $1.1M | $-1.9M | $-9.3M | $-1.3M |
| Net Income | $-9.5M | $-29.1M | $-100.1M | $44.2M | $-378.8M | $-29.2M | $-1.6M |
| Net Margin | -3.2% | -8.7% | -25.2% | 12.1% | -145.6% | -24.5% | -1.0% |
| EPS (Basic) | $-0.08 | $-0.23 | $-0.76 | $0.30 | $-3.71 | $-0.28 | $-0.02 |
| EPS (Diluted) | $-0.16 | $-0.36 | $-0.76 | $-0.23 | $-3.71 | $-0.28 | $-0.02 |
| Shares Outstanding (Basic) | 126.4M | 123.8M | 131.7M | 147.6M | 102.1M | 102.9M | 96.4M |
| Shares Outstanding (Diluted) | 135.8M | 142.5M | 131.7M | 148.5M | 102.1M | 102.9M | 96.4M |
| Dividends Per Share | — | — | — | — | — | — | — |